Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Decourt

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Journal of Alzheimer'S Disease & Parkinsonism|May 1, 2014
Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer's Related Pathological Changes in Down SyndromeBoris Decourt, William Mobley, Eric Reiman, et al.
Frontiers in Aging Neuroscience|June 26, 2026
Transsynaptic complex dysfunction in the hippocampus of Alzheimer's disease patientsAshly Hindle, Yong Chen, Xiangling Yin, et al.
Expert Opinion on Investigational Drugs|October 16, 2019
Clinical drug development for dementia with Lewy bodies: past and presentGaram Lee, Jeffrey Cummings, Boris Decourt, et al.
Journal of Neuroscience Research|November 21, 2008
Cortactin colocalizes with filopodial actin and accumulates at IgCAM adhesion sites in Aplysia growth conesBoris Decourt, Vidhya Munnamalai, Aih Cheun Lee, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Amyloid-Directed Antibodies: Past, Present, and FutureKeith Noorda, Kevin Noorda, Marwan N Sabbagh, et al.
Journal of Neuroscience Methods|September 6, 2011
Development of a specific ELISA to measure BACE1 levels in human tissuesAmanda Gonzales, Boris Decourt, Aaron Walker, et al.
Research Square|December 11, 2025
Correlations of CSF Biomarkers of Alzheimer's Disease with Cognitive Measures in MCI and AD Dementia: A Cross-Sectional AnalysisGabriel Bitar, Sierra Alban, Kassu Beyene, et al.
Expert Opinion on Investigational Drugs|April 26, 2021
Dementia with Lewy bodies: emerging drug targets and therapeuticsEvans D Pope, Laura Cordes, Jiong Shi, et al.
Current Neurology and Neuroscience Reports|June 10, 2021
Critical Appraisal of Amyloid Lowering Agents in ADBoris Decourt, Fadel Boumelhem, Evans D Pope, et al.
Journal of Alzheimer'S Disease Reports|May 13, 2021
Does Informant-Based Reporting of Cognitive Decline Correlate with Age-Adjusted Hippocampal Volume in Mild Cognitive Impairment and Alzheimer's Disease?Marwan Sabbagh, Justin Miller, Stephen Jones, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of Alzheimer'S Disease & Parkinsonism|May 1, 2014
Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer's Related Pathological Changes in Down SyndromeBoris Decourt, William Mobley, Eric Reiman, et al.
Frontiers in Aging Neuroscience|June 26, 2026
Transsynaptic complex dysfunction in the hippocampus of Alzheimer's disease patientsAshly Hindle, Yong Chen, Xiangling Yin, et al.
Expert Opinion on Investigational Drugs|October 16, 2019
Clinical drug development for dementia with Lewy bodies: past and presentGaram Lee, Jeffrey Cummings, Boris Decourt, et al.
Journal of Neuroscience Research|November 21, 2008
Cortactin colocalizes with filopodial actin and accumulates at IgCAM adhesion sites in Aplysia growth conesBoris Decourt, Vidhya Munnamalai, Aih Cheun Lee, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Amyloid-Directed Antibodies: Past, Present, and FutureKeith Noorda, Kevin Noorda, Marwan N Sabbagh, et al.
Journal of Neuroscience Methods|September 6, 2011
Development of a specific ELISA to measure BACE1 levels in human tissuesAmanda Gonzales, Boris Decourt, Aaron Walker, et al.
Research Square|December 11, 2025
Correlations of CSF Biomarkers of Alzheimer's Disease with Cognitive Measures in MCI and AD Dementia: A Cross-Sectional AnalysisGabriel Bitar, Sierra Alban, Kassu Beyene, et al.
Expert Opinion on Investigational Drugs|April 26, 2021
Dementia with Lewy bodies: emerging drug targets and therapeuticsEvans D Pope, Laura Cordes, Jiong Shi, et al.
Current Neurology and Neuroscience Reports|June 10, 2021
Critical Appraisal of Amyloid Lowering Agents in ADBoris Decourt, Fadel Boumelhem, Evans D Pope, et al.
Journal of Alzheimer'S Disease Reports|May 13, 2021
Does Informant-Based Reporting of Cognitive Decline Correlate with Age-Adjusted Hippocampal Volume in Mild Cognitive Impairment and Alzheimer's Disease?Marwan Sabbagh, Justin Miller, Stephen Jones, et al.
Pageof 5